135 related articles for article (PubMed ID: 18783701)
1. [Acute cholestatic hepatitis due to propylthiouracil].
Moral Moral P; Rodríguez Soler M; Mancheño Franch N; Aguilera Sánchez-Tello V; Todolí Parra J; Ponce García J; Calabuig Alborch JR
Gastroenterol Hepatol; 2008; 31(7):474-5. PubMed ID: 18783701
[No Abstract] [Full Text] [Related]
2. [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
Parolin MB; Lopes RW; Telles JE; Ioshii SO; Hajar N
Arq Gastroenterol; 2000; 37(2):129-32. PubMed ID: 11144016
[TBL] [Abstract][Full Text] [Related]
3. [Cholestatic hepatitis secondary to propylthiouracil].
Cofré C; Valdés E; Tapia A; Rodríguez J
Rev Med Chil; 1986 Jan; 114(1):42-4. PubMed ID: 3764142
[No Abstract] [Full Text] [Related]
4. Severe hepatotoxicity on beginning propylthiouracil therapy.
Lock DR; Sthoeger ZM
J Clin Gastroenterol; 1997 Jun; 24(4):267-9. PubMed ID: 9252857
[TBL] [Abstract][Full Text] [Related]
5. Propylthiouracil-induced hepatotoxicity.
Hardee JT; Barnett AL; Thannoun A; Eghtesad B; Wheeler D; Jamal MM
West J Med; 1996 Sep; 165(3):144-7. PubMed ID: 8909171
[No Abstract] [Full Text] [Related]
6. [Methimazole and propylthiouracil induced acute toxic hepatitis].
Casallo Blanco S; Valero MA; Marcos Sánchez F; de Matías Salces L; Blanco González JJ; Martín Barranco MJ
Gastroenterol Hepatol; 2007 May; 30(5):268-70. PubMed ID: 17493435
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more.
Malozowski S; Chiesa A
J Clin Endocrinol Metab; 2010 Jul; 95(7):3161-3. PubMed ID: 20610609
[No Abstract] [Full Text] [Related]
8. Propylthiouracil-induced hepatic damage.
Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Liver Injury: A Unique Presentation of Single-Dose Administration of Propylthiouracil.
Weissman S; Rajaratnam NG; Qureshi N; Inayat F; Elias S
J Investig Med High Impact Case Rep; 2020; 8():2324709620951323. PubMed ID: 32830568
[TBL] [Abstract][Full Text] [Related]
10. [Dissociated cholestasis: an uncommon complication of thioamide therapy].
Francés Artigas C; Nicolau Ramis J; Rivera Irigoín R; González Moreno J; Masmiquel Comas L
Endocrinol Nutr; 2013; 60(6):340-2. PubMed ID: 23036935
[No Abstract] [Full Text] [Related]
11. [Two cases of serious hepatic injury caused by antithyroid drugs].
Grzywa M; Orłowska-Florek R; Grzywa-Celińska A
Endokrynol Pol; 2009; 60(5):396-400. PubMed ID: 19885811
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring?
Benyounes M; Sempoux C; Daumerie C; Rahier J; Geubel AP
World J Gastroenterol; 2006 Oct; 12(38):6232-4. PubMed ID: 17036403
[TBL] [Abstract][Full Text] [Related]
13. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen.
Kuehn BM
JAMA; 2009 Jul; 302(4):369-71. PubMed ID: 19622807
[No Abstract] [Full Text] [Related]
14. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
[TBL] [Abstract][Full Text] [Related]
15. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
Rivkees SA; Szarfman A
J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
[TBL] [Abstract][Full Text] [Related]
16. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
Jain K; Chakrapani M; Smitha K
Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
[TBL] [Abstract][Full Text] [Related]
17. [Major adverse reactions to propylthiouracil in 586 cases of hyperthyroidism].
Frenkel J; Téllez R; Reyes C; González G; Michaud P
Rev Med Chil; 1993 Nov; 121(11):1289-94. PubMed ID: 8191137
[TBL] [Abstract][Full Text] [Related]
18. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
19. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
[TBL] [Abstract][Full Text] [Related]
20. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
Akmal A; Kung J
Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
